SRD5A3 was originally identified in hormone-refractory prostate tissue by genome-wide gene expression profiles and SRD5A3 inhibition also suppressed the proliferation of prostate cancer cells [21]. The gene discussed is SRD5A3; the disease is prostate cancer.